I Trademark

Trademark Overview


On Tuesday, September 6, 2022, a trademark application was filed for I with the United States Patent and Trademark Office. The USPTO has given the I trademark a serial number of 79351483. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, December 22, 2023. This trademark is owned by Idorsia Pharmaceuticals Ltd. The I trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for prevention or treatment of cardiovascular diseases, hypertension, vasospasms associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, autoimmune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, insomnia, anxiety disorders, drug addiction, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases and cancer
i

General Information


Serial Number79351483
Word MarkI
Filing DateTuesday, September 6, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, December 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for prevention or treatment of cardiovascular diseases, hypertension, vasospasms associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, autoimmune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, insomnia, anxiety disorders, drug addiction, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases and cancer
Pseudo MarkIDORSIA

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdorsia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, March 25, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, December 22, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, December 22, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, December 22, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 3, 2023REFUSAL PROCESSED BY IB
Thursday, June 8, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 8, 2023REFUSAL PROCESSED BY MPU
Saturday, April 22, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 21, 2023NON-FINAL ACTION WRITTEN
Thursday, April 20, 2023ASSIGNED TO EXAMINER
Tuesday, October 4, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 29, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB